Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Imaging And Path LabBOM:544482 -2.22%21 Days Inventory is 2.70 as of Mar. 2026, which is 20% below its 10-year median of 3.38. GuruFocus rates BOM:544482 with a GF Score™ of 21/100. Among 177 Medical Diagnostics & Research companies, Star Imaging And Path Lab ranks better than 98.31% on this metric.
The historical rank and industry rank for Star Imaging And Path Lab's Days Inventory or its related term are showing as below:
BOM:544482'
s Days Inventory Range Over the Past 10 Years
Min: 0.68 Med: 3.38 Max: 4.92
Current: 2.43
During the past 5 years, Star Imaging And Path Lab's highest Days Inventory was 4.92. The lowest was 0.68. And the median was 3.38.
BOM:544482's Days Inventory is ranked better than 98.31% of 177
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.64
vs BOM:544482: 2.43
Inventory Turnover measures how fast the company turns over its inventory within a year.
Star Imaging And Path Lab's Inventory Turnover for the
six
months ended in Mar. 2026 was 67.63.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Star Imaging And Path Lab's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.01.
Star Imaging And Path Lab (BOM:544482) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Star Imaging And Path Lab's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Star Imaging And Path Lab's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Star Imaging And Path Lab Days Inventory Related Terms
Star Imaging And Path Lab Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544482 vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Star Imaging And Path Lab's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Imaging And Path Lab Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Star Imaging And Path Lab's Days Inventory distribution charts can be found below:
* The bar in red indicates where Star Imaging And Path Lab's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Star Imaging And Path Lab (BOM:544482) has a Days Inventory of 2.70 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Star Imaging And Path Lab and its competitors. This is 20% below median its historical median of 3.38. Over the past decade, Star Imaging And Path Lab's Days Inventory has ranged from 0.68 to 4.92. According to the industry distribution chart, Star Imaging And Path Lab ranks #3 out of 177 companies in the Medical Diagnostics & Research industry, placing it in the top 1.7%.
Is Star Imaging And Path Lab's Days Inventory too high?
Star Imaging And Path Lab's current Days Inventory of 2.70 is 20% below median its 10-year median of 3.38. Over the past 10 years, this metric has ranged from a low of 0.68 to a high of 4.92. The Medical Diagnostics & Research industry median Days Inventory is 67.64. Star Imaging And Path Lab's value of 2.70 is 96% below this industry median. Based on the distribution chart, Star Imaging And Path Lab ranks #3 out of 177 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Star Imaging And Path Lab has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Star Imaging And Path Lab's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Star Imaging And Path Lab ranks #3 out of 177 companies for Days Inventory. This places Star Imaging And Path Lab in the top 2% of its industry — outperforming the majority of peers. The industry median Days Inventory is 67.64. Star Imaging And Path Lab's value of 2.70 is 96% below this benchmark. Historically, Star Imaging And Path Lab's own Days Inventory has ranged from 0.68 to 4.92 over the past decade. While the company's 10-year median is 3.38 vs. the industry median of 67.64, Star Imaging And Path Lab has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 67.64, based on 177 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Imaging And Path Lab's current Days Inventory of 2.70 is 96% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Star Imaging And Path Lab and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 67.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Imaging And Path Lab's current Days Inventory is 2.70, which is 20% below median its own 10-year median of 3.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Imaging And Path Lab stock overvalued right now?
Star Imaging And Path Lab (BOM:544482) has a current Days Inventory of 2.70. The current Days Inventory is 2.70, which is 20% below median its 10-year median of 3.38 and 96% below the Medical Diagnostics & Research industry median of 67.64. Star Imaging And Path Lab's overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Star Imaging And Path Lab (BOM:544482), the current Days Inventory is 2.70 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Star Imaging And Path Lab Ltd operates a diagnostic testing network, NABL accredited, delivering pathology, radiology, Cardiology, and Neurology services in Delhi and Uttar Pradesh. It offers a comprehensive range of diagnostic imaging services and clinical laboratory tests, including both routine and specialized studies and profiles. These services are essential for the prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. The company's diagnostic imaging and radiology services encompass X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry, and mammography.
21GF Score
Get the complete analysis for BOM:544482
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544482 has been successfully added to your 
